Profound Risk News Today

ProFound Cloud redefines accessibility to critical insights, empowering radiologists in early breast cancer detection

Partnership to expand access to ProFound Breast Health Suite and CancerIQ’s platform to benefit patients across thousands of facilities 

ICAD (Nasdaq:ICAD) today announced plans to present new studies validating its AI-powered ProFound Breast Health Suite.

Partnership to expand access to ProFound Breast Health Suite and CancerIQ’s platform to benefit patients across thousands of facilities

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The transformative power of artificial intelligence (AI) — with regards t...

The technology uses AI to provide women with personalized risk estimations one to two years ahead of time, even when a current mammogram comes back clear.

The technology uses AI to provide women with personalized risk estimations one to two years ahead of time, even when a current mammogram comes back clear.

ICAD earnings call for the period ending March 31, 2022.

iCAD (ICAD) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. iCAD (NASDAQ: ICAD) You may begin. Investor Relations Thank you, Devon, and good afternoon, everyone. Thank you for participating in todays call. Joining me from iCAD are Michael Klein, chairman and chief executive officer; Stacey Stevens, president; and Scott Areglado, chief financial officer. Earlier this afternoon, iCAD announced financial result...